Digital Health Trends in Europe take center stage in the ever-evolving landscape of 2023, signifying a critical juncture as the industry gracefully matures, shifting away from the heightened expectations of 2021. The sector no longer rides the waves of hype but is now anchored in delivering real value and meeting dynamic customer needs in an intensely competitive market.

French ventures faced challenges, reaching only 22% of 2022 values, while German and Swiss counterparts exceeded the previous year’s funding by over 20%. Notably, Europe has risen to the second-highest total venture capital investment in Digital Health globally, surpassing the Asia Pacific region.

This evolution is significantly accelerated by a staggering 37% year-on-year decline in venture funding, dropping to $22 billion over the past two years. This global trend reflects a substantial reduction in investor appetite across all regions. Concurrently, major ecosystem players, including Health Systems and Biopharma, are awakening to the transformative potential of digital solutions in enhancing productivity and healthcare outcomes. Actively seeking ventures armed with proof points, they lay the groundwork for collaborative developments in the future.

Galen Growth’s 2023 Year-End Report: A Deep Dive into European Digital Health Dynamics

We are pleased to introduce Galen Growth’s 2023 Year-End Report on Digital Health Key Trends in Europe — an in-depth analysis transcending the superficial. This comprehensive report focuses on private ventures, active partnerships, regulatory approvals, venture funding strength, and more. Powered by HealthTech Alpha, the world’s leading Digital Health private market data, intel, and insights platform, this report delivers unmatched, no-bias, no-hype, and data-driven coverage of the European Digital Health ecosystem.

Venture Funding Landscape: A Rollercoaster of Challenges and Triumphs

The report outlines a 42% year-on-year decrease in Digital Health venture funding in Europe in 2023. While French ventures grappled with a substantial funding drop, reaching only 22% of 2022 values, their German and Swiss counterparts exceeded the previous year’s funding by over 20%. Remarkably, despite the sustained decline in funding activity, Europe has risen to the second-highest total venture capital investment in Digital Health, surpassing the Asia Pacific region. However, the landscape could become challenging as many ventures face critical funding shortages, reaching a tipping point for funding strength.

Europe’s Leadership: A Beacon of Evidence and Innovation

At the close of 2023, Europe has positioned itself as a global leader in the Digital Health ecosystem, with 30% of ventures achieving an Evidence Signal above 40. This signifies that these ventures have undergone clinical trials, obtained regulatory approvals, or published multiple peer-reviewed papers. Europe’s strength in innovation and evidence not only underscores its significance within the regional landscape but also positions it prominently at the forefront of the global Digital Health narrative.

Delving into Clusters and Disease Areas

The report delves into clusters, spotlighting the Wellness and Health Management Solutions clusters. Remarkably, the Wellness cluster secured $415 million in venture funding in 2023, the highest among Digital Health clusters, attributed to mega deals by eGym and Urban Sports Club, leading to a 3.2x year-on-year increase. Notably, the only other European-founded venture in the Wellness cluster with a mega deal in the past five years was the Finnish-founded venture Oura in a 2021 Series C funding round. The report also conducts an in-depth examination of the Oncology and Cardiovascular Diseases disease areas, featuring companies like Alentis Therapeutics (Switzerland), BioSerenity (France), and Luma Vision (Ireland).

AI Adoption: Navigating the Technological Frontier

In Europe, 42% of private Digital Health ventures leverage AI or Generative AI (GenAI) technologies. Impressively, 45% of these ventures focus primarily on Medical Diagnostics or Patient Solutions, showcasing a commitment to cutting-edge technologies. GenAI technology finds its place in the Research Solutions Cluster for 8% of ventures, while 67% opt for other forms of AI technology.

Global Funding Dynamics: Europe’s Rise to Prominence

In a significant milestone for Europe in 2023, the region surpassed the Asia Pacific for the first time, securing 14% of the global funding value in Digital Health. Meanwhile, North America maintains its dominance, commanding a formidable 70% of the funding value.

Unlocking the Comprehensive Insights: Premium Report Access

For those eager to navigate the intricacies of Digital Health trends, our 70+ page premium report is available for download. Premium HealthTech Alpha subscribers can access it immediately, while others can purchase this invaluable resource from the Galen Growth Research page.

Unlocking a wealth of in-depth analysis on investment trends, pipeline maturity, Digital Health category focus, clinical and therapeutic focus, noteworthy deals, partnerships, and proof points, this premium report serves as your passport to understanding nuanced dynamics shaping the future of Digital Health in Europe as we embark on the journey of 2024.

Access the Premium Report for HealthTech Alpha Premium Subscribers:

Purchase the Full Report on Galen Growth Research Page: